ManiMNICF 93 Receivables Turnover is 2.77 as of Feb. 2026. GuruFocus rates MNICF with a GF Score™ of 93/100 and a GF Value™ of $15.57. The stock has 7 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Mani ranks better than 89.77% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Mani's Revenue for the
three
months ended in Feb. 2026 was $53.4 Mil. Mani's average Accounts Receivable for the
three
months ended in Feb. 2026 was $19.3 Mil.
Hence, Mani's Receivables Turnover for the
three
months ended in Feb. 2026 was 2.77.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Mani Receivables Turnover Related Terms
Mani Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Mani's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MNICF vs ISRG, BDX, MDLN: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Mani's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mani Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mani's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Mani's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mani (MNICF) has a Receivables Turnover of 2.77 as of Feb. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Mani and its competitors. According to the industry distribution chart, Mani ranks #83 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 10.2%.
Is Mani's Receivables Turnover too high?
Mani's current Receivables Turnover is 2.77. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Mani's value of 2.77 is 49.7% below this industry median. Based on the distribution chart, Mani ranks #83 out of 811 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Mani has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Mani's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mani ranks #83 out of 811 companies for Receivables Turnover. This places Mani in the top 10% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.51. Mani's value of 2.77 is 49.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mani's current Receivables Turnover of 2.77 is 49.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Mani and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mani's current Receivables Turnover is 2.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mani stock overvalued right now?
Mani (MNICF) has a current Receivables Turnover of 2.77. The stock's GF Value™ is $15.57, compared to a current price of $12.82 — trading 17.7% below its estimated fair value. The current Receivables Turnover is 2.77 and 49.7% below the Medical Devices & Instruments industry median of 5.51. Mani's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Mani (MNICF), the current Receivables Turnover is 2.77 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mani (MNICF) Overvalued in 2026?
Based on GuruFocus' analysis, Mani stock appears to be undervalued.
The current stock price of $12.82 is trading 17.7% below its estimated GF Value™ of $15.57.
Key valuation signals for MNICF:
Receivables Turnover: 2.77
GF Value™: $15.57 vs. price of $12.82 (17.7% below fair value)
Industry Position: 49.7% below the Medical Devices & Instruments median (#83 of 811)
No single metric tells the full story. See the MNICF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
93GF Score
Get the complete analysis for MNICF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNICF has been successfully added to your 
